DUBLIN--(BUSINESS WIRE)--The "Global Infusion Pumps Market Analysis & Trends - Industry Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Infusion Pumps Market is poised to grow strong during the forecast period 2017 to 2025. Some of the prominent trends that the market is witnessing include high demand for smart pumps to reduce medication errors, increase in demand for dmbulatory infusion pumps, technological developments in health care and growth opportunities/investment opportunities.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
Key Topics Covered
1 Market Outline
2 Executive Summary
3 Market Overview
4 Infusion Pumps Market, by Application
5 Infusion Pumps Market, by End User
6 Infusion Pumps Market, by Product
7 Infusion Pumps Market, by Geography
8 Key Player Activities
9 Leading Companies
- Becton, Dickinson and Company (BD)
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Se & Co. KGaA
- Pfizer Inc.
- Johnson & Johnson
- Medtronic PLC
- Moog Inc.
- Smiths Medical (A Division of Smiths Group PLC)
- Terumo Corporation
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
- Animas Corporation
- F.Hoffmann-La Roche Ltd.
- Halyard Health, Inc.
- Hospira, Inc
For more information about this report visit https://www.researchandmarkets.com/research/cx3rld/global_infusion?w=4